Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
NUZYRA: selected primary-label renal guidance and limits
Product / population
Adult NUZYRA IV and oral products for their labeled infections; the usual route-specific loading and administration instructions remain necessary.
Renal method
Qualitative renal categories, including ESRD on hemodialysis
Source revision
05/2026
Retrieved
2026-11-07
Local review status
Selected sections checked against the identified source; not a complete monograph or independent clinician approval.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
NUZYRA: source applicability and renal evidence limits
Do not infer a CRRT schedule or interchangeable oral/IV loading. The RX mirror is not independent corroboration of the matched label.
What to reconcile: Review oral fasting and cation-separation instructions.
DailyMed / product prescribing information · Adult NUZYRA IV and oral products for their labeled infections; the usual route-specific loading and administration instructions remain necessary.
Renal method: Qualitative renal categories, including ESRD on hemodialysis Source date: 05/2026 Retrieved: 2026-11-07
Qualified no-adjustment statement. Apply only to the population, product and renal range described in this source.
Before using this finding
Do not infer a CRRT schedule or interchangeable oral/IV loading.
Selected sections checked against the identified source; not a complete monograph or independent clinician approval.
Section 8.7; oral administration context in section 2
No renal dose adjustment is warranted in mild, moderate or severe impairment, including ESRD receiving hemodialysis. This does not replace the indication- and route-specific loading regimen. Oral tablets require fasting and separation from dairy, antacids and multivitamins; confirm the full administration instructions. No CRRT regimen is established in the selected passages.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v7.4. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.
